Pfizer

Showing 15 posts of 894 posts found.

Pfizer

Pfizer signs Chinese commercial collaboration

May 9, 2011
Sales and Marketing China, Pfizer, Shanghai Pharmaceutical Co

US giant Pfizer looks set to collaborate with Shanghai Pharmaceutical Co. on business opportunities in China. The potential partnership is …

Pfizer

Pfizer sales flat as Lipitor revenues decline

May 4, 2011
Sales and Marketing Pfizer

Pfizer’s sales decreased slightly in the first quarter after rising revenues in specialty care and emerging markets failed to offset …

Strides Arcolab facility gets the nod from FDA

May 3, 2011
Manufacturing and Production Pfizer, distribution issues

Indian pharmaceutical manufacturer Strides Arcolab has been given a green light from the FDA for a facility in Bangalore that’s …

Pfizer

Deaths reported in Pfizer arthritis trial

April 26, 2011
Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Four deaths have been reported in a late-stage study of Pfizer’s arthritis drug tofacitinib. Three of the deaths are thought …

Pfizer

Phase III boost for Pfizer’s oral arthritis drug

April 18, 2011
Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Pfizer’s rheumatoid arthritis treatment tofacitinib has induced clinical remission of the disease according to one-year data from a phase III …

Pfizer sells drug delivery unit Capsugel for $2.38bn

April 5, 2011
Manufacturing and Production Capsugel, Kohlberg Kravis Roberts & Co, Pfizer, pharmaceutical capsules

Pfizer has agreed to sell its Capsugel unit to private equity firm Kohlberg Kravis Roberts & Co. for $2.38 billion …

Pfizer Real Danger medicine spam

Digital Pharma: Social media boost for Pfizer anti-counterfeits campaign

March 28, 2011
Medical Communications Digital Pharma blog, Pfizer, counterfeits

Pfizer UK is using social media to reinvigorate its Real Danger patient safety campaign. The next phase of the campaign, …

Pfizer's Sandwich research facility

Pfizer’s CRO plans for Sandwich will have limited impact

March 15, 2011
Business Services, Research and Development Jobs, Kent, Pfizer, Sandwich, job cuts

Pfizer’s efforts to attract contract research organisations to take over part of its Sandwich research site will only benefit a …

Bayer-helmed oncology biomarker project launched

March 14, 2011
Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology

A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …

Pfizer sells Irish manufacturing facility to Amgen

March 14, 2011
Manufacturing and Production Amgen, Dun Laoghaire, Ireland, Pfizer, pharma manufacturing, pharma manufacturing in Ireland

Amgen has come to the rescue of 280 workers whose jobs were threatened by the closure of a manufacturing facility …

Sanofi's VTE avatar

Digital Pharma: online campaign directory updated

March 4, 2011
Medical Communications, Sales and Marketing Digital Pharma blog, Novartis, Pfizer, Sanofi-Aventis, VTE, diabetes, erectile dysfunction, pharmacist educaiton, venous thromboembolism, viagra

The latest update to the Digital Pharma links directory covers its online campaigns section and includes a pharmacist networking portal …

Science minister David Willetts

Universities to ‘pick up pharma’s R&D mantle’ after Pfizer closure

March 3, 2011
Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee, UK research, UK science, job cuts

Science in the UK will have to focus on contractually-based research in the future as pharma’s R&D presence in the …

Pfizer drops 15 pipeline projects

March 1, 2011
Research and Development Lyrica, Pfizer, Pfizer R&D, Pfizer product pipeline, Pfizer research, inotuzumab, pregabalin

Pfizer has again slimmed down its product pipeline as the US giant looks to cut R&D spending and sharpen its …

Pfizer in break up talks for Sandwich research site

March 1, 2011
Research and Development Kent, Pfizer, Sandwich, job cuts

Pfizer is in confidential talks over the future of its Sandwich, Kent research facility that could see the site broken …

viiv_gsk_pfizer_david_redfern

David Redfern appointed ViiV chairman

February 28, 2011
Research and Development, Sales and Marketing David Redfern, GSK, GlaxoSmithKline, Pfizer, ViiV, ViiV Healthcare, appointment, research and development, sales and marketing

David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.

The Gateway to Local Adoption Series

Latest content